Active, Not Recruiting
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
NCT05956626
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
- Locations
-
- Associated Retina Consultants Phoenix, Arizona, United States
- Retinal Consultants Medical Group Sacramento, California, United States
- Vitreo Retinal Associates, P.A. Gainesville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States